A double blinded randomized trial comparing a new GM-CSF, LEUCOTROPIN™, and LEUCOMAX® for myeloid reconstitution following autologous peripheral blood stem cell transplantation (APBSCT).

被引：0
|
作者：
Sinclair, CJD
Bence-Bruckler, I
Turner, AR
Bredeson, C
Stewart, DA
Poynton, CH
Hatton, CSR
Couban, S
Howson-Jan, K
Marcus, R
Genereux, M
Ede, M
Stewart, DI
机构：
[1] Cangene Corp, Winnipeg, MB, Canada
[2] Univ Ottawa, Ottawa, ON K1N 6N5, Canada
[3] Univ Alberta, Edmonton, AB T6G 2M7, Canada
[4] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[5] Univ Calgary, Calgary, AB T2N 1N4, Canada
[6] Univ Wales Hosp, Cardiff CF4 4XW, S Glam, Wales
[7] John Radcliffe Hosp, Oxford OX3 9DU, England
[8] Dalhousie Univ, Halifax, NS B3H 3J5, Canada
[9] Univ Western Ontario, London, ON N6A 3K7, Canada
[10] Addenbrookes Hosp, Cambridge, England
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3415
引用
收藏
页码：866A / 866A
页数：1
相关论文
共 50 条
  • [41] Administration of granulocyte macrophage-colony stimulating factor (GM-CSF) increases dendritic cells following autologous stem cell transplantation.
    Tzolas, AC
    Witte, J
    Perry, K
    Tian, L
    Boyette, RM
    Iturraspe, J
    Sugrue, M
    Fisk, D
    Wingard, JR
    Reddy, V
    BLOOD, 2002, 100 (11) : 403B - 403B
  • [42] Delayed use of granulocyte colony-stimulating factor (G-CSF) following autologous peripheral blood stem cell transplantation (APBSCT) does not affect engraftment or hospital stay.
    Haddad, R
    Rapoport, AP
    Cottler-Fox, M
    Chen, T
    Tricot, G
    Fassas, A
    BLOOD, 1999, 94 (10) : 357B - 357B
  • [43] A prospective randomized trial comparing the toxicity and safety of atovaquone versus trimethoprim/sulfarieteioxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
    Colby, C
    McAfee, SL
    Sackstein, R
    Finkelstein, D
    Fishman, JA
    Spitzer, TR
    BLOOD, 1998, 92 (10) : 278A - 278A
  • [44] Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trial
    Schmitz, N
    Ljungman, P
    Cordonnier, C
    Kempf, C
    Linkesch, W
    Alegre, A
    Solano, C
    Simonsson, B
    Sonnen, R
    Diehl, V
    Fischer, T
    Caballero, D
    Littlewood, T
    Noppeney, R
    Schafhausen, P
    Jost, L
    Delabarre, F
    Marcus, R
    BONE MARROW TRANSPLANTATION, 2004, 34 (11) : 955 - 962
  • [45] Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trial
    N Schmitz
    P Ljungman
    C Cordonnier
    C Kempf
    W Linkesch
    A Alegre
    C Solano
    B Simonsson
    R Sonnen
    V Diehl
    T Fischer
    D Caballero
    T Littlewood
    R Noppeney
    P Schafhausen
    L Jost
    F Delabarre
    R Marcus
    Bone Marrow Transplantation, 2004, 34 : 955 - 962
  • [46] Evaluation of Myeloid and Lymphoid Regulatory Cell Populations in the Peripheral Blood of Patients Receiving GM-CSF in a Vaccine-Based Immunotherapy Clinical Trial
    Olson, Walter C.
    McSkimming, Chantel
    Slingluff, Craig L.
    JOURNAL OF IMMUNOTHERAPY, 2010, 33 (08) : 872 - 873
  • [47] GM-CSF secreting leukemia cell vaccinations after allogeneic non-myeloablative peripheral blood stem cell transplantation in patients with advanced myelodysplastic syndrome or refractory acute myeloid leukemia
    Ho, VT
    Dranoff, G
    Pasek, M
    MacDonell, R
    Cutler, C
    Lee, SJ
    Alyea, EP
    Antin, JH
    Soiffer, RJ
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 17 - 18
  • [48] Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia
    Oehler, VG
    Radich, JP
    Storer, I
    Blume, KG
    Chauncey, T
    Clift, R
    Snyder, DS
    Forman, SJ
    Flowers, MED
    Martin, P
    Guthrie, KA
    Negrin, RS
    Appelbaum, FR
    Bensinger, W
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 85 - 92
  • [49] A multicentric randomized clinical trial comparing single vs double autologous peripheral blood stem cell transplantation for patients with newly diagnosed multiple myeloma: Results of an interim analysis.
    Tosi, P
    Cavo, M
    Zamagni, E
    Ronconi, S
    Benni, M
    Tura, S
    BLOOD, 1999, 94 (10) : 715A - 715A
  • [50] EUROPEAN DOUBLE-BLIND RANDOMIZED TRIAL OF GM-CSF IN PATIENTS AFTER TRANSPLANTATION OF T-CELL DEPLETED BONE-MARROW
    NISSEN, C
    STERN, A
    JONES, T
    SCHAEDELIN, J
    SPECK, B
    DEWITTE, T
    WILLENZE, R
    GORDONSMITH, EC
    GLUCKMAN, E
    MARMONT, A
    EXPERIMENTAL HEMATOLOGY, 1988, 16 (06) : 518 - 518
12345